Marder SR, Umbricht D. Negative symptoms in schizophrenia: newly emerging measurements, pathways, and treatments. Schizophr Res. 2023;258:71–7.

Article  PubMed  Google Scholar 

Waltz JA, Gold JM. Motivational deficits in schizophrenia and the representation of expected value. Curr Top Behav Neurosci. 2016;27:375–410.

Article  PubMed  PubMed Central  Google Scholar 

Strauss GP, Bartolomeo LA, Harvey PD. Avolition as the core negative symptom in schizophrenia: relevance to pharmacological treatment development. NPJ Schizophr. 2021;7:16.

Article  PubMed  PubMed Central  Google Scholar 

Gold JM, Strauss GP, Waltz JA, Robinson BM, Brown JK, Frank MJ. Negative symptoms of schizophrenia are associated with abnormal effort-cost computations. Biol Psychiatry. 2013;74:130–6.

Article  PubMed  PubMed Central  Google Scholar 

Bailey MR, Simpson EH, Balsam PD. Neural substrates underlying effort, time, and risk-based decision making in motivated behavior. Neurobiol Learn Mem. 2016;133:233–56.

Article  PubMed  PubMed Central  Google Scholar 

Singh T, Poterba T, Curtis D, Akil H, Al Eissa M, Barchas JD, et al. Rare coding variants in ten genes confer substantial risk for schizophrenia. Nature. 2022;604:509–16.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Trubetskoy V, Pardinas AF, Qi T, Panagiotaropoulou G, Awasthi S, Bigdeli TB, et al. Mapping genomic loci implicates genes and synaptic biology in schizophrenia. Nature. 2022;604:502–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Canetta SE, Brown AS. Prenatal infection, maternal immune activation, and risk for schizophrenia. Transl Neurosci. 2012;3:320–27.

Article  PubMed  Google Scholar 

Stilo SA, Murray RM. Non-genetic factors in schizophrenia. Curr Psychiatry Rep. 2019;21:100.

Article  PubMed  PubMed Central  Google Scholar 

Creese I, Burt DR, Snyder SH. Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs. Science. 1976;192:481–3.

Article  CAS  PubMed  Google Scholar 

Seeman P, Lee T. Antipsychotic drugs: direct correlation between clinical potency and presynaptic action on dopamine neurons. Science. 1975;188:1217–9.

Article  CAS  PubMed  Google Scholar 

Abi-Dargham A, Rodenhiser J, Printz D, Zea-Ponce Y, Gil R, Kegeles LS. et al. Increased baseline occupancy of D2 receptors by dopamine in schizophrenia. Proc Natl Acad Sci USA. 2000;97:8104–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Weinstein JJ, Chohan MO, Slifstein M, Kegeles LS, Moore H, Abi-Dargham A. Pathway-specific dopamine abnormalities in schizophrenia. Biol Psychiatry. 2017;81:31–42.

Article  CAS  PubMed  Google Scholar 

McCutcheon RA, Abi-Dargham A, Howes OD. Schizophrenia, dopamine and the striatum: from biology to symptoms. Trends Neurosci. 2019;42:205–20.

Kegeles LS, Slifstein M, Xu X, Urban N, Thompson JL, Moadel T. et al. Striatal and extrastriatal dopamine D2/D3 receptors in schizophrenia evaluated with [18F] fallypride positron emission tomography. Biol Psychiatry. 2010;68:634–41.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Howes OD, Montgomery AJ, Asselin MC, Murray RM, Valli I, Tabraham P, et al. Elevated striatal dopamine function linked to prodromal signs of schizophrenia. Arch Gen Psychiatry. 2009;66:13–20.

Article  PubMed  Google Scholar 

Simpson EH, Kellendonk C, Kandel E. A possible role for the striatum in the pathogenesis of the cognitive symptoms of schizophrenia. Neuron. 2010;65:585–96.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Schizophrenia Working Group of the Psychiatric Genomics C. Biological insights from 108 schizophrenia-associated genetic loci. Nature. 2014;511:421–7.

Article  Google Scholar 

Tepper JM, Sharpe NA, Koos TZ, Trent F. Postnatal development of the rat neostriatum: electrophysiological, light- and electron-microscopic studies. Dev Neurosci. 1998;20:125–45.

Article  CAS  PubMed  Google Scholar 

Krajeski RN, Macey-Dare A, van Heusden F, Ebrahimjee F, Ellender TJ. Dynamic postnatal development of the cellular and circuit properties of striatal D1 and D2 spiny projection neurons. J Physiol. 2019;597:5265–93.

Article  CAS  PubMed  Google Scholar 

Lieberman OJ, McGuirt AF, Mosharov EV, Pigulevskiy I, Hobson BD, Choi S, et al. Dopamine triggers the maturation of striatal spiny projection neuron excitability during a critical period. Neuron. 2018;99:540–54.e4.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kozorovitskiy Y, Saunders A, Johnson CA, Lowell BB, Sabatini BL. Recurrent network activity drives striatal synaptogenesis. Nature. 2012;485:646–50.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Peixoto RT, Wang W, Croney DM, Kozorovitskiy Y, Sabatini BL. Early hyperactivity and precocious maturation of corticostriatal circuits in Shank3B(-/-) mice. Nat Neurosci. 2016;19:716–24.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Aberman JE, Salamone JD. Nucleus accumbens dopamine depletions make rats more sensitive to high ratio requirements but do not impair primary food reinforcement. Neuroscience. 1999;92:545–52.

Article  CAS  PubMed  Google Scholar 

Nunes EJ, Randall PA, Podurgiel S, Correa M, Salamone JD. Nucleus accumbens neurotransmission and effort-related choice behavior in food motivation: effects of drugs acting on dopamine, adenosine, and muscarinic acetylcholine receptors. Neurosci Biobehav Rev. 2013;37:2015–25.

Article  CAS  PubMed  Google Scholar 

Randall PA, Pardo M, Nunes EJ, Lopez Cruz L, Vemuri VK, Makriyannis A, et al. Dopaminergic modulation of effort-related choice behavior as assessed by a progressive ratio chow feeding choice task: pharmacological studies and the role of individual differences. PLoS ONE. 2012;7:e47934.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mingote S, Font L, Farrar AM, Vontell R, Worden LT, Stopper CM, et al. Nucleus accumbens adenosine A2A receptors regulate exertion of effort by acting on the ventral striatopallidal pathway. J Neurosci. 2008;28:9037–46.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Carvalho Poyraz F, Holzner E, Bailey MR, Meszaros J, Kenney L, Kheirbek MA, et al. Decreasing striatopallidal pathway function enhances motivation by energizing the initiation of goal-directed action. J Neurosci. 2016;36:5988–6001.

Article  PubMed  PubMed Central  Google Scholar 

Olivetti PR, Balsam PD, Simpson EH, Kellendonk C. Emerging roles of striatal dopamine D2 receptors in motivated behaviour: Implications for psychiatric disorders. Basic Clin Pharmacol Toxicol. 2019;126:47–55.

Simpson EH, Gallo EF, Balsam PD, Javitch JA, Kellendonk C. How changes in dopamine D2 receptor levels alter striatal circuit function and motivation. Mol Psychiatry. 2022;27:436–44.

Article  CAS  PubMed  Google Scholar 

Gallo EF, Meszaros J, Sherman JD, Chohan MO, Teboul E, Choi CS, et al. Accumbens dopamine D2 receptors increase motivation by decreasing inhibitory transmission to the ventral pallidum. Nat Commun. 2018;9:1086.

Article  PubMed  PubMed Central  Google Scholar